NCT04082988View on ClinicalTrials.gov

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

May 22, 2020

Study Completion Date

May 22, 2020

Conditions
NSCLC, Stage IV
Interventions
DIAGNOSTIC_TEST

18F-FDG PET-CT

18F-FDG PET-CT scan

Trial Locations (2)

1007 MD

VU medical center, Amsterdam

2333 ZA

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

The Netherlands Cancer Institute

OTHER